Stock Market ChatCOMMUNITY + RESEARCHMember login TCRT NEWS
Browse source-backed SMC News Room coverage tagged TCRT, newest first.
4 published articles tagged TCRT.
SMC verified a headline (Oct. 14) linking TCRT to an acquisition tied to Alaunos/Velaris Therapeutics. Tape shows heavy premarket and session volume with follow‑through; SMC classifies the move as an acquisition/buyout news runner and carries explicit cautionary flags. This is a headline-driven event that can materially change ownership/exit expectations for the small‑cap.
SMC verified an acquisition headline linking Velaris Therapeutics to TCRT (published Oct. 14). The tape shows outsized premarket volume and a follow‑through run; SMC classifies this as an acquisition/buyout news runner with explicit 'not chaseable' warnings. Traders should treat the move as headline-driven and wait for official deal disclosures.
Alaunos’s acquisition headline linking Velaris Therapeutics to TCRT is confirmed on the tape; SMC flags the move as an acquisition/buyout runner with outsized volume and explicit 'not chaseable' warnings.
Confirmed: market data show a headline (published 2026-10-14) linking TCRT to an acquisition — “Alaunos acquires Velaris Therapeutics.” Premarket tape shows TCRT up ~6.1% to $3.97 with ~13.16M shares and ~23.3x relative volume; the move is labeled an acquisition/buyout runner and is news‑confirmed in the overview.